FierceBiotech2d
FDA clears its first treatment for dry AMD, with LumiThera's light-based Valeda system
The FDA has cleared its first light-based therapy for dry age-related macular degeneration—which the agency described as ...
Medscape2d
Age-Related Macular Degeneration Highlights From AAO 2024
Practice-changing studies in dry age-related macular degeneration (AMD) and promising new directions in wet AMD, presented at ...
Daily1d
FDA authorises marketing of light therapy as treatment of AMD
The US Food and Drug Administration has FDA has granted marketing authorization to a form of light therapy as the first-ever ...
ophthalmologytimes2d
LumiThera’s Valeda Light Delivery System receives marketing authorization from FDA
The Valeda Light Delivery System is for the treatment of patients with dry age-related macular degeneration (AMD).
WebMD11d
The Importance of Timing in Wet AMD Treatment
While there's no cure for wet age-related macular degeneration (AMD), there are ways to slow the disease and help you see better for longer. But early detection and timely treatment hold the key ...
FDA authorises marketing of LumiThera’s dry AMD treatment device
The US Food and Drug Administration (FDA) has granted marketing authorisation for LumiThera’s Valeda Light Delivery System to ...
GEN4d
Wet AMD Treatments Could Work Better If Both VEGF and ANGPTL4 Are Targeted
Study points to approach to improving anti-VEGF therapy for all wet AMD patients, and help subset of patients who lose vision ...